BioSpace News Archive

Joseph Miller, MD, MS, a physician at the Henry Ford Health System in Detroit, MI, and a key Principal Investigator on CalciMedica’s initial acute pancreatitis clinical study of its calcium release-activated calcium channel inhibitor CM4620-IE, presented on the study at the annual meeting of the American College of Emergency Physicians being held in Denver, CO from October 27-30.

Conformis, Inc., a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific joint replacement implants designed to fit each patient’s unique anatomy, announced financial results for the third quarter ended September 30, 2019.

MacroGenics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, announced that the Company will release its financial results for the third quarter of 2019 after the market closes on Wednesday, November 6, 2019.

RhoVac AB announces, 30th October 2019, that Mikael Ørum will leave the board and the chair of the board, Gunnar Gårdemyr, who was elected to the board in May 2018, takes over as the chairman of the board.

A large study analyzing 107,000 knee replacement surgeries found that African Americans were significantly more likely than white patients to be discharged to an inpatient rehabilitation or skilled nursing facility rather than home care after the procedure.

Vetter’s core competencies include the manufacturing of safe, user-friendly, complex packaging systems such as the assembly of pens, autoinjectors and safety devices.

The American Diabetes Association (ADA) strongly supports the introduction of the Insulin Price Reduction Act in the United States House of Representatives.

Alleges OncoSec Board Breached Fiduciary Duty by Agreeing to China Grand Takeover Proposal at Depressed Price with No Effort to Explore Alternative Transactions or Financing Sources

AliveCor, the leader in AI based, personal ECG technology, and provider of enterprise cardiology solutions; and Huami Corporation (NYSE:HMI), a global leader in biometric, data-driven wearables, today announced a multi-faceted global strategic alliance that combines the technologies of each company to deliver a new generation of medical functionality to wearable devices.

Moberg Pharma AB (publ)'s (“Moberg Pharma” or the “Company”) Annual General Meeting took place today in the Company’s premises in Bromma